Clinical trials
Leukemia, Myeloid, Acute trials with no applicable phase and unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2007 | 1 |
| 2010 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut Paoli-Calmettes | 3 |
| CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 2 |
| Huihan Wang | 2 |
| Jianxiang Wang | 2 |
| LanZhou University | 2 |
| PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2 |
| Rambam Health Care Campus | 2 |
| Affiliated Hospital to Academy of Military Medical Sciences | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 35 |
| Leukemia | 3 |
| Lymphoma | 3 |
| Myelodysplastic Syndromes | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Congenital Abnormalities | 2 |
| Hodgkin Disease | 2 |
| Myelodysplastic-Myeloproliferative Diseases | 2 |
| Myeloproliferative Disorders | 2 |
| Recurrence | 2 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.